Copyright © Inderes 2011 - present. All rights reserved.
Log in to your Inderes Free account to see all free content on this page.
Create account

OrganoClick

1.79

 

SEK

 

-3.24 %

Less than 1K followers

ORGC

First North Stockholm

Chemicals

Basic Materials

-3.24%
-11.82%
-27.53%
-37.63%
-37.63%
-55.8%
-43.71%
-69.45%
-74.97%

OrganoClick operates in environmental technology. The company offers specialized solutions based on fiber-based materials, where the company develops, produces and markets functional fiber chemistry. The products are mainly used in water-repellent fabrics and primarily in wood treatment to protect against fungal decay and fire. The company was founded in 2006 and has its headquarters in Täby.

Read more
Market cap
175.63M SEK
Turnover
127.38K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
5.8.
2025

Extraordinary general meeting '25

5.11.
2025

Interim report Q3'25

12.2.
2026

Annual report '25

ShowingAll content types
Third party research

OrganoClick: Q2 in line with PW, rights issue announced - ABG

Q2 figures in line with pre-announcement The Q2 figures were in line with the profit warning issued on 11 July, i.e. sales of SEK 30m (-23% y-o-y) and an EBIT of SEK -4.7m (-0.1m). FW sales were, as pre-announced in the PW, SEK 10.6m (-34% y-o-y). Sales...

OrganoClick

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Third party research

Organoclick: Weak Q2 triggers PW - ABG

- Q2 sales SEK 30m, EBIT -4.7m (vs. ABGSCe 37m and -0.4m) - Costs savings of SEK 3m per year from Q4 - Cash balance SEK 2m in Q2, 10m loan booked in Q3 Sales and EBIT miss of SEK 7m and 4m vs. ABGSCe This morning, OrganoClick issued a PW and presented...

OrganoClick
Third party research

OrganoClick: NW&FT weakness to continue, set for better H2 - ABG

- Report out 18 July - Q2e: sales SEK 37m, -3% y-o-y, EBIT SEK -0.1m - Headwinds in NW&FT and FW, good momentum in GC&MP Q2 expectations We estimate Q2 sales of SEK 37m, -3% y-o-y and +6% q-o-q. We expect GC&MP will remain the growth driver (+9% y-o-...

OrganoClick
Third party research

OrganoClick: ABGSC Investor Days feedback - ABG

Strong momentum in GC&MP, headwinds in NW&FT and FW '25e-'27e sales CAGR of +14% New product launches in NW&FT expected at end of '25 Headwinds in NW&FT and FW, GC&MP continues to grow Today, we hosted OrganoClick's CEO Mårten Hellberg at ABGSC's Investor...

OrganoClick
Third party research

OrganoClick: Slow start to '25e, but consumer brands strong - ABG

Sales down 7% y-o-y, headwinds from weak end-markets persist Cut '25e-'27e sales by 4-2%, EBIT by SEK 3.5m on soft Q1 Consumer products showing good momentum Recovery delayed, but good development in GC&MP OrganoClick reported Q1 sales of SEK 35m (-7...

OrganoClick
Third party research

OrganoClick: Sales miss driven by NW&FT and FW - ABG

Sales -9%, adj. EBIT -2.6m vs. ABGSCe Miss driven by NW&FT and FW, GC&MP continues to grow Total liquidity of SEK 5.7m Q1 results Sales came in at SEK 35m (-9% vs. ABGSCe 39m), -7% y-o-y (-7% org.). EBIT adj. was SEK -2.1m (vs. ABGSCe 0.52m), for a margin...

OrganoClick
Third party research

OrganoClick: Last quarter of tough comps in NW&FT - ABG

Report out 6 May Q1e: sales SEK 39m, +2% y-o-y, EBIT SEK 0.5m (0.2m) Optimistic on GC&MP, cautious on FW & NW&FT Q1 expectations For Q1, we estimate sales of SEK 39m, up 1.5% y-o-y, marking a return to growth after four quarters of decline. We expect...

OrganoClick
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.